FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On December 30, 2005
Table of Contents
Docket # Title
1987F-0179 Sucrose polyester as replacement for fats & oil in food
1992V-0278 Laser Light Show
2005D-0330 Guidance for Industry and FDA Review Staff on Collection of Platelets by Automated Methods
2005N-0343 Agency Emergency Processing Under OMB Review; Guidance for Requesting an Extension to Use Existing Label Stock after the Trans Fat Labeling Effective Date of January 1, 2006
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
2005P-0509 Evaluation that Psychosis Is a Adverse effect of Keppra (levetiracetam)
1987F-0179 Sucrose polyester as replacement for fats & oil in food
RPT 7 Center for Science in the Public Interest (CSPI) Vol #: 43
1992V-0278 Laser Light Show
VRA 5 FDA/CDRH Vol #: 1
2005D-0330 Guidance for Industry and FDA Review Staff on Collection of Platelets by Automated Methods
C 14 Blood Bank of San Bernardino and Riverside Counties Vol #: 3
C 15 T. Peterman Vol #: 3
C 16 Blood Bank of Redwoods Vol #: 3
C 17 LifeShare Blood Centers Vol #: 3
C 18 Community Blood Center/Community Tissue Services (CBS/CTS) Vol #: 3
EXT 3 The Institute for Transfusion Medicine Vol #: 3
2005N-0343 Agency Emergency Processing Under OMB Review; Guidance for Requesting an Extension to Use Existing Label Stock after the Trans Fat Labeling Effective Date of January 1, 2006
LET 2 FUJI Natural Food, Inc. (FUJI) Vol #: 1
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
C 79 J. Sisson Vol #: 2
C 80 M. Lowe Vol #: 2
C 81 D. Weese Vol #: 2
C 82 Eligible Vol #: 2
C 83 J. Ers Vol #: 2
C 84 S. Willits Vol #: 2
C 85 P. Leon Vol #: 2
C 86 T. Gunter Vol #: 2
C 87 J. Miller Vol #: 2
C 88 H. Hogan Vol #: 2
C 89 A. Gifford Vol #: 2
C 90 D. Granger Vol #: 2
C 91 T. Blend, MD Vol #: 2
C 92 G. Kropinicki Vol #: 2
C 93 M. Patreno Vol #: 2
C 94 M. Citoli Vol #: 2
C 95 Rowland Strickland Vol #: 2
C 96 J. Dimidio Vol #: 2
C 97 E. Easley Vol #: 2
C 98 L. Leibowitz, PhD Vol #: 2
EMC 1 T. Accuntius Vol #: 2
2005P-0509 Evaluation that Psychosis Is a Adverse effect of Keppra (levetiracetam)
ACK 1 HFA- 305 to W. Rucker Vol #: 1
CP 1 W. Rucker Vol #: 1

Page created on January 20, 2006 kk

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management